Evidence map›Paper›PMID 28278271›Full record

ArticlePloS one2017

Evaluating association between linguistic characteristics of abstracts and risk of bias: Case of Japanese randomized controlled trials.

Daisuke Yoneoka, Erika Ota

Abstract readEvaluation Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daisuke YoneokaGraduate school of Medicine, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3525-5092
Erika OtaGraduate School of Nursing Science, St Juke's International University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the ongoing growth in the number of published randomized controlled trials (RCTs) and increased quality assessment of RCTs, the association between the quality and characteristics in the text has not been sufficiently studied. We are interested in a specific question: what kind of sentences is a good indicator of high quality RCTs? To help researchers to efficiently screen articles worth reading, this study aims 1) to quantify the linguistic features of articles and 2) to build a document assessment model to evaluate quality of RCTs using only the abstract. All RCTs that were conducted in Japan in 2010 as original articles were included in the analysis. Data were independently assessed by two reviewers using a risk-of-bias tool. Three aspects of linguistic style were quantitatively measured, and a document model was constructed to evaluate the RCTs. A total of 302 RCTs were selected for quality assessment. Of these, 255 articles were assessed as high quality and 47 as low quality. High-quality articles tended to use longer words than low-quality articles (p = 0.048), however sentences were generally shorter (p = 0.004). Further, high-quality articles included a larger proportion of noun phrases (p = 0.026) but a smaller proportion of verb phrases (p = 0.041). The optimal number of topics to assess the quality of articles was four, while two topics had a significant association with quality. Despite a number of articles published about RCTs in Japan, significant differences exist in several textual features between high- and low-quality RCTs. Instead of the risk-of-bias tool, these results can be used as the new criteria to rapidly screen valuable articles and it also revealed quality control of RCT articles is urgently needed in Japan.

Indexed as

BiasHumansJapanLinguisticsPublishingQuality ControlRandomized Controlled Trials as Topic

Identifiers

PMID28278271
PMCPMC5344454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.